Healthcare / Health Information ServicesOslo
$35.00
-0.60 (-1.67%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 35% · confianza 10%
FCF escenarios
weak_data · normalized FCF $-7.4M · quality 13.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
23/100
D
Piotroski
7/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$718M
P/E
108.6x
↑EV/EBITDA
8.2x
↓ROE
39.6%
↑Gross Margin
93.2%
↑Debt/Equity
29.33
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+10.5%
FCF CAGR
—
FCF margin
-4.4%
FCF / Net income
-3.29x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $494.2M · net income $6.6M · FCF $-21.8M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $494.2M | $494.2M | $425.0M | $410.5M | $366.7M |
| Net Income | $6.6M | $6.6M | $-66.7M | $104.3M | $-131.6M |
| EBITDA | $138.1M | $138.1M | $41.5M | $227.9M | $-10.3M |
| EPS | 0.32 | 0.32 | -3.25 | 5.11 | -6.28 |
| Gross Margin | 93.2% | 93.2% | 92.7% | 92.2% | 90.9% |
| Operating Margin | 10.2% | 10.2% | -0.5% | -2.0% | -20.0% |
| Net Margin | 1.3% | 1.3% | -15.7% | 25.4% | -35.9% |
| Balance Sheet | |||||
| Debt/Equity | 29.33 | 29.33 | 28.33 | 5.01 | 17.18 |
| Current Ratio | 0.67 | 0.67 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-21.8M | $-21.8M | $32.1M | $-7.4M | $-30.2M |
| Returns | |||||
| ROE | 39.6% | 39.6% | -391.3% | 109.5% | -457.4% |
| Valuation | |||||
| P/E | 108.62 | 108.62 | — | 7.22 | — |
| EV/EBITDA | 8.16 | 8.16 | 25.14 | 4.89 | — |
| P/B | 43.07 | 43.07 | 39.69 | 7.91 | — |
| Growth & Yield | |||||
| Revenue Growth | 16.3% | 16.3% | 3.5% | 11.9% | — |
| EPS Growth | 109.9% | 109.9% | -163.7% | 181.4% | — |
| Dividend Yield | 1.3% | 1.3% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
112.8%
EPS terminal req.
$3.11
Spread vs growth
-2.9%
5Y implied EPS CAGR
63.4%
EPS terminal req.
$3.76
Spread vs growth
46.5%
10Y implied EPS CAGR
34.1%
EPS terminal req.
$6.05
Spread vs growth
75.8%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-32.3%
Start / end P/E
n/dx → n/dx
EPS bridge
-3.25 → 0.32
Residual
-33.6%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.